Evidence map›Paper›PMID 28194179›Full record

ArticleJournal of oncology2017

The Prognostic Role of NEDD9 and P38 Protein Expression Levels in Urinary Bladder Transitional Cell Carcinoma.

Ola A Harb, Rasha Haggag, Maged M Ali, Shereen El Shorbagy, Abeer M Abdelbary, Lobna A Abdelaziz, Reham A Salim, Khaled M Abdel Wahab

Open access · hybridAbstract read
In one paragraph

Article in Journal of oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma.International journal of molecular sciences · 2022
    Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ola A HarbDepartment of Pathology, Faculty of Medicine, Zagazig University, Sharkia, Egypt.ORCID 0000-0002-4396-3101
Rasha HaggagDepartment of Medical Oncology, Faculty of Medicine, Zagazig University, Sharkia, Egypt.ORCID 0000-0002-4319-375X
Maged M AliDepartment of Urology, Faculty of Medicine, Zagazig University, Sharkia, Egypt.
Shereen El ShorbagyDepartment of Medical Oncology, Faculty of Medicine, Zagazig University, Sharkia, Egypt.
Abeer M AbdelbaryDepartment of Pathology, Faculty of Medicine, Zagazig University, Sharkia, Egypt.
Lobna A AbdelazizDepartment of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Zagazig University, Sharkia, Egypt.
Reham A SalimDepartment of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Zagazig University, Sharkia, Egypt.
Khaled M Abdel WahabDepartment of Urology, Faculty of Medicine, Zagazig University, Sharkia, Egypt.
Zagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28194179
PMCPMC5282419
OpenAlexW2578874450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.